Cargando…
Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method
There is an increasing interest in the generation of Fc‐fusion molecules to exploit the effector functions of Fc and the fusion partner, towards improving the therapeutic potential. The Fc‐fusion molecules have unique structural and functional attributes that impart various advantages. However, the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100451/ https://www.ncbi.nlm.nih.gov/pubmed/36333865 http://dx.doi.org/10.1002/bit.28281 |
_version_ | 1785025280928120832 |
---|---|
author | Datola, Antonio Satwekar, Abhijeet Barron, Nadine DeRosa, Sawako Tomascak, Brittany Dawson, Jessica Palmese, Angelo Rossi, Mara |
author_facet | Datola, Antonio Satwekar, Abhijeet Barron, Nadine DeRosa, Sawako Tomascak, Brittany Dawson, Jessica Palmese, Angelo Rossi, Mara |
author_sort | Datola, Antonio |
collection | PubMed |
description | There is an increasing interest in the generation of Fc‐fusion molecules to exploit the effector functions of Fc and the fusion partner, towards improving the therapeutic potential. The Fc‐fusion molecules have unique structural and functional attributes that impart various advantages. However, the manufacturing of Fc‐fusion molecules possesses certain challenges in the biopharmaceutical development. The fusion of unnaturally occurring two or more domains in a construct can pose problems for proper folding and are prone to aggregation and degradation. Reshuffling of disulfide bridges represents a posttranslational event that affects folding. This can play a critical role in the correct structure of a molecule and leads to structural heterogeneity in biotherapeutics; it may also impact the in vivo biological activities, safety, and efficacy of the biopharmaceutical. Our work presents an investigation case of a doublet band, as observed only in nonreducing sodium dodecyl sulfate ‐ polyacrylamide gel electrophoresis (SDS‐PAGE) for a bi‐specific, N‐ and C‐terminal Fc‐fusion molecule. Other characterization and orthogonal methods from the analytical panel did not indicate the presence of two distinct species, including the orthogonal CE‐SDS (Caliper Lab Chip GXII). Therefore, it was necessary to determine if the phenomenon was an analytical artifact or a real variant of our Fc‐fusion molecule. With the comprehensive mass spectrometry‐based characterization, we were able to determine that the doublet band was related to the reshuffling of one disulfide bridge in one of the fused domains. Our work illustrates the application of nonreducing peptide mapping by mass spectrometry to characterize and identify disulfide variants in a complex N‐ and C‐terminal Fc‐fusion molecule, and further adoption to monitor the disulfide structural variants in the intermediate process samples to drive the manufacturing of a consistent product with the desired quality attributes. |
format | Online Article Text |
id | pubmed-10100451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101004512023-04-14 Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method Datola, Antonio Satwekar, Abhijeet Barron, Nadine DeRosa, Sawako Tomascak, Brittany Dawson, Jessica Palmese, Angelo Rossi, Mara Biotechnol Bioeng ARTICLES There is an increasing interest in the generation of Fc‐fusion molecules to exploit the effector functions of Fc and the fusion partner, towards improving the therapeutic potential. The Fc‐fusion molecules have unique structural and functional attributes that impart various advantages. However, the manufacturing of Fc‐fusion molecules possesses certain challenges in the biopharmaceutical development. The fusion of unnaturally occurring two or more domains in a construct can pose problems for proper folding and are prone to aggregation and degradation. Reshuffling of disulfide bridges represents a posttranslational event that affects folding. This can play a critical role in the correct structure of a molecule and leads to structural heterogeneity in biotherapeutics; it may also impact the in vivo biological activities, safety, and efficacy of the biopharmaceutical. Our work presents an investigation case of a doublet band, as observed only in nonreducing sodium dodecyl sulfate ‐ polyacrylamide gel electrophoresis (SDS‐PAGE) for a bi‐specific, N‐ and C‐terminal Fc‐fusion molecule. Other characterization and orthogonal methods from the analytical panel did not indicate the presence of two distinct species, including the orthogonal CE‐SDS (Caliper Lab Chip GXII). Therefore, it was necessary to determine if the phenomenon was an analytical artifact or a real variant of our Fc‐fusion molecule. With the comprehensive mass spectrometry‐based characterization, we were able to determine that the doublet band was related to the reshuffling of one disulfide bridge in one of the fused domains. Our work illustrates the application of nonreducing peptide mapping by mass spectrometry to characterize and identify disulfide variants in a complex N‐ and C‐terminal Fc‐fusion molecule, and further adoption to monitor the disulfide structural variants in the intermediate process samples to drive the manufacturing of a consistent product with the desired quality attributes. John Wiley and Sons Inc. 2022-11-17 2023-02 /pmc/articles/PMC10100451/ /pubmed/36333865 http://dx.doi.org/10.1002/bit.28281 Text en © 2022 Merck Serono SpA. Biotechnology and Bioengineering published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | ARTICLES Datola, Antonio Satwekar, Abhijeet Barron, Nadine DeRosa, Sawako Tomascak, Brittany Dawson, Jessica Palmese, Angelo Rossi, Mara Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title | Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title_full | Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title_fullStr | Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title_full_unstemmed | Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title_short | Comprehensive investigation of a structural variant in a bi‐specific, N‐and C‐terminal Fc‐fusion molecule, and its monitoring with LC‐MS based method |
title_sort | comprehensive investigation of a structural variant in a bi‐specific, n‐and c‐terminal fc‐fusion molecule, and its monitoring with lc‐ms based method |
topic | ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100451/ https://www.ncbi.nlm.nih.gov/pubmed/36333865 http://dx.doi.org/10.1002/bit.28281 |
work_keys_str_mv | AT datolaantonio comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT satwekarabhijeet comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT barronnadine comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT derosasawako comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT tomascakbrittany comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT dawsonjessica comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT palmeseangelo comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod AT rossimara comprehensiveinvestigationofastructuralvariantinabispecificnandcterminalfcfusionmoleculeanditsmonitoringwithlcmsbasedmethod |